Empagliflozin treatment decreased the expression of the inflammatory cytokines IL-1β, IL-6, and CCL2; the percentage of inflammatory monocytes and inducible NO synthase–positive macrophages; and IFN response genes Stat1 and CXCL9 during influenza infection. This evidence concerns the gene STAT1 and influenza.